🔗 www.linkedin.com/feed/update/...
Watch below and explore the latest PxWire, avac.org/pxwire/
#HIV #PrEP #HIVprevention #AIDS2026
🔗 www.linkedin.com/feed/update/...
Watch below and explore the latest PxWire, avac.org/pxwire/
#HIV #PrEP #HIVprevention #AIDS2026
But gaps remain, including the exclusion of Brazil & other countries from the license.
Read more: avac.org/resource/rep...
#PrEP #HIV
But gaps remain, including the exclusion of Brazil & other countries from the license.
Read more: avac.org/resource/rep...
#PrEP #HIV
@hivpxresearch.bsky.social
@hivpxresearch.bsky.social
bit.ly/4y0pPn1 @avac.org
bit.ly/4y0pPn1 @avac.org
bit.ly/4wavJSi @avac.org
lenacapavir etc
bit.ly/4wavJSi @avac.org
lenacapavir etc
bit.ly/475Z8Tq
@avac.org
bit.ly/475Z8Tq
@avac.org
Also out today is AVAC's latest issue of PxWire, which breaks down the latest PEPFAR data—showing declines in PrEP initiations and what’s still missing.
avac.org/resource/rep...
Also out today is AVAC's latest issue of PxWire, which breaks down the latest PEPFAR data—showing declines in PrEP initiations and what’s still missing.
avac.org/resource/rep...
AVAC breaks down the latest #PEPFAR data—showing declines in #PrEP initiations and what’s still missing—amid ongoing fallout from funding cuts. Plus: what new #LEN commitments really mean, and a look at the long-acting #HIV pipeline.
Read more: avac.org/resource/rep...
AVAC breaks down the latest #PEPFAR data—showing declines in #PrEP initiations and what’s still missing—amid ongoing fallout from funding cuts. Plus: what new #LEN commitments really mean, and a look at the long-acting #HIV pipeline.
Read more: avac.org/resource/rep...
#PxWire #HIVprevention
#PxWire #HIVprevention
#HIVprevention #HIV
#HIVprevention #HIV
Read it all here: avac.org/pxwire/
@eltonjohnaidsfoundation.org @ciffchild.bsky.social @gatesfoundation.bsky.social @unitaid.bsky.social
Read it all here: avac.org/pxwire/
@eltonjohnaidsfoundation.org @ciffchild.bsky.social @gatesfoundation.bsky.social @unitaid.bsky.social
FDA approval of injectable #lenacapavir for #PrEP brings promise, but US cuts to #HIV prevention & research threaten progress. This issue unpacks the KP program shutdowns, LEN’s market potential, and why investment in innovation must continue.
Read: avac.org/resource/pxw...
FDA approval of injectable #lenacapavir for #PrEP brings promise, but US cuts to #HIV prevention & research threaten progress. This issue unpacks the KP program shutdowns, LEN’s market potential, and why investment in innovation must continue.
Read: avac.org/resource/pxw...
Read the full issue, avac.org/resource/pxw...
Read the full issue, avac.org/resource/pxw...